凯胺的临床毒理学
Leo J Schep1, Robin J Slaughter2, Martin Watts3
1Professional Practice Fellow, Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Clinical toxicology (Philadelphia, Pa.)
|June 2, 2023
概括
胺,用于医疗和娱乐,可以引起急性神经精神疾病和慢性问题,如囊炎和胆管病变. 管理重点是对急性毒性进行支持性护理,对长期影响进行戒断.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
背景情况:
- 胺是一种具有止痛功能的分离性麻醉剂.
- 它作为一种娱乐性药物获得了普及,特别是在舞蹈文化中.
- 娱乐性胺使用与各种不良影响有关.
研究的目的:
- 审查胺毒性的流行病学,毒性机制,药理动力学,临床特征,诊断和管理.
- 综合当前关于凯胺在医疗和娱乐用途中的不良影响的知识.
主要方法:
- 在OVID MEDLINE和Web of Science数据库中使用"胺"和毒性相关的关键词进行了全面的文献搜索.
- 包括病例报告,病例系列,药理动力学研究,相关动物药理学研究和评论.
- 排除非临床人体研究,评论,社论和尸检调查.
主要成果:
- 胺的机制涉及对N-甲基-D-酸盐受体的对抗作用.
- 药理动力学显示吸收速度快,肝脏对活性代谢物的广泛代谢,主要通过排泄,半衰期为1.5-5小时.
- 急性影响包括意识受损和幻觉;慢性使用可能导致囊炎和胆血管病变.
结论:
- 胺的娱乐性使用带来了急性神经精神影响和慢性泌尿生殖和胆道损伤的风险.
- 诊断包括临床表现和针对慢性疾病的特定测试.
- 治疗主要是对急性毒性有助于治疗,而戒断是慢性影响的关键.
相关概念视频
Parenteral Anesthetics: Overview
163
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
163
Toxic Reactions: Overview
1.0K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.0K
Local Anesthetics: Adverse Effects
462
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
462
Physical Properties of Amines
3.3K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.3K
Antidotes
701
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
701
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
210
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
210


